Inspira Medical Company
"Intravascular Oxygenation Device."
Inspira Medical has developed a respiratory support technology for use as an alternative to mechanical ventilation. The company’s intravascular oxygenation device, OXSPIRA, safely increases oxygen levels and reduces carbon dioxide in the venous blood, enabling physicians to address the primary ventilatory condition without the enormous complications associated with mechanical ventilation.
Inspira Medical filed for an international PCT in January 2019, and additional patents for its technology and software are currently in progress.
Combating Coronavirus Pandemic:
Inspira Medical's solution helps address the Coronavirus Pandemic.
Inspira Medical has developed a respiratory support technology for use as an alternative to mechanical ventilation. The company’s intravascular oxygenation device, OXSPIRA, safely increases oxygen levels and reduces carbon dioxide in the venous blood, enabling physicians to address the primary ventilatory condition without the enormous complications associated with mechanical ventilation.
Inspira Medical filed for an international PCT in January 2019, and additional patents for its technology and software are currently in progress.
Combating Coronavirus Pandemic:
Inspira Medical's solution helps address the Coronavirus Pandemic.
Technology:
COVID Treatments
Industry:
HealthTech
Headquarters:
Israel
Founded Date:
2018
Employees Number:
N/A
Funding Status:
N/A
Register and Claim Ownership